Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Keeok Haam
Effect of Combined Anti-Pd-1 and Temozolomide Therapy in Glioblastoma
OncoImmunology
Oncology
Allergy
Immunology
Related publications
Temozolomide Nanoparticles for Targeted Glioblastoma Therapy
ACS Applied Materials & Interfaces
Medicine
Materials Science
Nanotechnology
Nanoscience
SCLE and Dermatomyositis in Anti‐PD‐1 Therapy
British Journal of Dermatology
Dermatology
Medicine
Crosslink Between Temozolomide and PD-L1 Immune-Checkpoint Inhibition in Glioblastoma Multiforme
BMC Cancer
Cancer Research
Oncology
Genetics
Tumoral and Immune Heterogeneity in an Anti-Pd-1 Responsive Glioblastoma: A Case Study
Cold Spring Harbor molecular case studies
Biochemistry
Molecular Medicine
Genetics
PD-L1 Expression and Combined Status of PD-L1/PD-1–Positive Tumor Infiltrating Mononuclear Cell Density Predict Prognosis in Glioblastoma Patients
Journal of Pathology and Translational Medicine
Forensic Medicine
Pathology
Histology
Transcriptional Mechanisms of Resistance to Anti–PD-1 Therapy
Clinical Cancer Research
Cancer Research
Oncology
Robust Antitumor Effects of Combined Anti-Cd4-Depleting Antibody and Anti-Pd-1/Pd-L1 Immune Checkpoint Antibody Treatment in Mice
Cancer immunology research
Cancer Research
Immunology
Expression of LAG-3 and Efficacy of Combination Treatment With Anti-Lag-3 and Anti-Pd-1 Monoclonal Antibodies in Glioblastoma
International Journal of Cancer
Cancer Research
Oncology
Rationale of Combination of Anti-Pd-1/Pd-L1 Antibody Therapy and Radiotherapy for Cancer Treatment
International Journal of Clinical Oncology
Medicine
Surgery
Oncology
Hematology